全文获取类型
收费全文 | 54篇 |
免费 | 11篇 |
出版年
2021年 | 2篇 |
2018年 | 1篇 |
2017年 | 2篇 |
2015年 | 3篇 |
2014年 | 1篇 |
2013年 | 4篇 |
2012年 | 3篇 |
2011年 | 1篇 |
2010年 | 3篇 |
2009年 | 1篇 |
2008年 | 1篇 |
2007年 | 1篇 |
2006年 | 1篇 |
2004年 | 2篇 |
2002年 | 1篇 |
2000年 | 1篇 |
1999年 | 4篇 |
1997年 | 2篇 |
1996年 | 3篇 |
1992年 | 2篇 |
1991年 | 2篇 |
1990年 | 1篇 |
1989年 | 1篇 |
1986年 | 1篇 |
1985年 | 2篇 |
1984年 | 1篇 |
1983年 | 2篇 |
1981年 | 2篇 |
1979年 | 2篇 |
1978年 | 3篇 |
1975年 | 1篇 |
1973年 | 2篇 |
1972年 | 3篇 |
1969年 | 1篇 |
1967年 | 1篇 |
1966年 | 1篇 |
排序方式: 共有65条查询结果,搜索用时 15 毫秒
51.
Martijn A. Langereis Huib H. Rabouw Melle Holwerda Linda J. Visser Frank J. M. van Kuppeveld 《Journal of virology》2015,89(21):11169-11173
It is well known that plasmid DNA transfection, prior to virus infection, negatively affects infection efficiency. Here, we show that cytosolic plasmid DNA activates the cGAS/STING signaling pathway, which ultimately leads to the induction of an antiviral state of the cells. Using a transient one-plasmid clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9 system, we generated cGAS/STING-knockout cells and show that these cells can be infected after plasmid DNA transfection as efficiently as nontransfected cells. 相似文献
52.
53.
54.
Marcelo Filonzi Laís C Cardoso Maristela T Pimenta Daniel BC Queiróz Maria CW Avellar Catarina S Porto Maria FM Lazari 《Reproductive biology and endocrinology : RB&E》2007,5(1):29
Background
Relaxin is the endogenous ligand of the G-protein coupled receptor RXFP1, previously known as LGR7. In humans relaxin can also activate, but with lower affinity, the closely related receptor for the insulin-like peptide from Leydig cells, RXFP2, previously known as LGR8. The lack of relaxin impairs male fertility but the precise distribution and the function of relaxin receptors in the male reproductive tract is not known. We investigated the distribution of Rxfp1 and Rxfp2 in the reproductive tract of the male rat and the function of relaxin in the vas deferens, a tissue with high expression of both receptors. 相似文献55.
NR Campbell Burgess E BC Choi G Taylor E Wilson J Cleroux JG Fodor LA Leiter D Spence 《CMAJ》1999,160(9):S1-S6
OBJECTIVE: To provide updated, evidence-based recommendations for health care professionals on lifestyle changes to prevent and control hypertension in otherwise healthy adults (except pregnant women). OPTIONS: For people at risk for hypertension, there are a number of lifestyle options that may avert the condition--maintaining a healthy body weight, moderating consumption of alcohol, exercising, reducing sodium intake, altering intake of calcium, magnesium and potassium, and reducing stress. Following these options will maintain or reduce the risk of hypertension. For people who already have hypertension, the options for controlling the condition are lifestyle modification, antihypertensive medications or a combination of these options; with no treatment, these people remain at risk for the complications of hypertension. OUTCOMES: The health outcomes considered were changes in blood pressure and in morbidity and mortality rates. Because of insufficient evidence, no economic outcomes were considered. EVIDENCE: A MEDLINE search was conducted for the period January 1996 to September 1996 for each of the interventions studied. Reference lists were scanned, experts were polled, and the personal files of the authors were used to identify other studies. All relevant articles were reviewed, classified according to study design and graded according to level of evidence. VALUES: A high value was placed on the avoidance of cardiovascular morbidity and premature death caused by untreated hypertension. BENEFITS, HARMS AND COSTS: Lifestyle modification by means of weight loss (or maintenance of healthy body weight), regular exercise and low alcohol consumption will reduce the blood pressure of appropriately selected normotensive and hypertensive people. Sodium restriction and stress management will reduce the blood pressure of appropriately selected hypertensive patients. The side effects of these therapies are few, and the indirect benefits are well known. There are certainly costs associated with lifestyle modification, but they were not measured in the studies reviewed. Supplementing the diet with potassium, calcium and magnesium has not been associated with a clinically important reduction in blood pressure in people consuming a healthy diet. RECOMMENDATIONS: (1) It is recommended that health care professionals determine the body mass index (weight in kilograms/[height in metres]2) and alcohol consumption of all adult patients and assess sodium consumption and stress levels in all hypertensive patients. (2) To reduce blood pressure in the population at large, it is recommended that Canadians attain and maintain a healthy body mass index. For those who choose to drink alcohol intake should be limited to 2 or fewer standard drinks per day (maximum of 14/week for men and 9/week for women). Adults should exercise regularly. (3) To reduce blood pressure in hypertensive patients, individualized therapy is recommended. This therapy should emphasize weight loss for overweight patients, abstinence from or moderation in alcohol intake, regular exercise, restriction of sodium intake and, in appropriate circumstances, individualized cognitive behaviour modification to reduce the negative effects of stress. VALIDATION: The recommendations were reviewed by all of the sponsoring organizations and by participants in a satellite symposium of the fourth international Conference on Preventive Cardiology. They are similar to those of the World Hypertension League and the Joint National committee, with the exception of the recommendations on stress management, which are based on new information. They have not been clinically tested. SPONSORS: The Canadian Hypertension Society, the Canadian Coalition for High Blood Pressure Prevention and Control, the Laboratory Centre for Disease Control at health Canada, and the Heart and Stroke Foundation of Canada. 相似文献
56.
57.
D A Holwerda M Veldhuizen-Tsoerkan P R Veenhof E Evers 《Comparative biochemistry and physiology. B, Comparative biochemistry》1989,92(2):375-380
1. On aerial exposure, pyruvate kinase is inactivated in various organs of M. edulis; the decrease of activity is slower in muscle than in non-muscular tissue. 2. Anoxic in vitro incubation of gills results in a rapid inactivation of pyruvate kinase. No change occurs in an aerated medium. 3. Enzyme inactivation is mimicked in part by oxic incubation in an acidified medium containing 5,5-dimethyloxazolidine-2,4-dione, and by the action of calcium ionophore A23187. 4. Incubation of supernatant of gill homogenate results in a slow inactivation of pyruvate kinase that is inhibited by trifluoperazine or EGTA and stimulated by exogenous calmodulin. 5. Addition of ATP plus cAMP stimulates pyruvate kinase inactivation in supernatant of homogenized muscle but not so in a high molecular weight fraction thereof. 相似文献
58.
59.
Philip Vkovski Mitra Gultom Jenna N. Kelly Silvio Steiner Julie Russeil Bastien Mangeat Elisa Cora Joern Pezoldt Melle Holwerda Annika Kratzel Laura Laloli Manon Wider Jasmine Portmann Thao Tran Nadine Ebert Hanspeter Stalder Rune Hartmann Vincent Gardeux Daniel Alpern Bart Deplancke Volker Thiel Ronald Dijkman 《PLoS biology》2021,19(3)
60.
Laccases isolated from the lacquer tree Rhus vernicifera and the fungus Polyporus versicolor show fluorescence emission near 420 nm and phosphorescence emission in the 440–465 nm region. The fluorescence and phosphorescence excitation spectra for both laccases show maxima in the 315–330 nm range, a spectral region corresponding to the absorbance maxima for the type 3 binuclear Cu centers of the two enzymes. Additional evidence is presented for the association of the newly discovered emissions with the type 3 Cu centers of the two laccases. 相似文献